Inovio Pharmaceuticals (INO) Posts Q1 Results with Data Ahead - Maxim Group
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- L3Harris CEO steps down amid conduct review, shares drop
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Reddit leads social media platforms in revenue growth per user
Inovio Pharmaceuticals, Inc. (INO) Turns Positive
May 12, 2014 2:46 PM EDTInovio Pharmaceuticals, Inc. (AMEX: INO) is moving along with broader markets. Shares are now positive on the session.
Following Q1 results, Inovio dropped as much as 13.4 percent to $1.87. The stock has been crawling back since just after 10am.
Shares are about 0.2 percent higher.
... MoreInovio Pharmaceuticals, Inc. (INO) Posts Q1 Loss of 5c/Share; Updates on Cash Position
May 12, 2014 6:12 AM EDTInovio Pharmaceuticals, Inc. (AMEX: INO) reported Q1 EPS of ($0.05), $0.01 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $2.4 million versus the consensus estimate of $1.41 million.
As of March 31, 2014, cash and cash equivalents plus short-term investments were $116.8 million compared with $52.6... More
